Neuropsychiatric disturbances in atypical parkinsonian disorders
暂无分享,去创建一个
[1] J. Rowe,et al. Neurotransmitter deficits from frontotemporal lobar degeneration , 2018, Brain : a journal of neurology.
[2] A. Berardelli,et al. Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome , 2017, Front. Neurol..
[3] Murray Grossman,et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.
[4] G. Wenning,et al. Multiple system atrophy: insights into a rare and debilitating movement disorder , 2017, Nature Reviews Neurology.
[5] M. Zappia,et al. Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor. , 2016, Parkinsonism & related disorders.
[6] A. Berardelli,et al. MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome , 2016, Journal of Neurology.
[7] E. Matsubara,et al. Brain Perfusion in Corticobasal Syndrome with Progressive Aphasia , 2016, Dementia and Geriatric Cognitive Disorders Extra.
[8] F. Niccolini,et al. Cholinergic imaging in dementia spectrum disorders , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[9] A. Berardelli,et al. Primary motor cortex LTP/LTD-like plasticity in probable corticobasal syndrome. , 2016, Journal of neurophysiology.
[10] J. Grafman,et al. Neuropsychiatric effects of neurodegeneration of the medial versus lateral ventral prefrontal cortex in humans , 2015, Cortex.
[11] Ke Chen,et al. The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy , 2015, PloS one.
[12] M. Haut,et al. Completed suicide in a case of clinically diagnosed progressive supranuclear palsy. , 2015, Neurodegenerative disease management.
[13] A. Strafella,et al. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment , 2015, The Lancet Neurology.
[14] K. Abe,et al. Simultaneous assessment of cognitive and affective functions in multiple system atrophy and cortical cerebellar atrophy in relation to computerized touch-panel screening tests , 2015, Journal of the Neurological Sciences.
[15] M. Stamelou,et al. Atypical parkinsonism: diagnosis and treatment. , 2015, Neurologic clinics.
[16] E. Tolosa,et al. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.
[17] A. Berardelli,et al. Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study. , 2014, Parkinsonism & related disorders.
[18] H. Akiyama,et al. Corticobasal degeneration initially developing motor versus non‐motor symptoms: a comparative clinicopathological study , 2014, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[19] W. Poewe,et al. Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group , 2014, Movement disorders : official journal of the Movement Disorder Society.
[20] I. Litvan,et al. Behavioral abnormalities in progressive supranuclear palsy , 2013, Psychiatry Research.
[21] A. Berardelli,et al. Fifty years of progressive supranuclear palsy , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[22] M. Stamelou,et al. Atypical parkinsonism: an update , 2013, Current opinion in neurology.
[23] E. Tolosa,et al. A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type , 2013, Journal of Neural Transmission.
[24] Mark Hallett,et al. Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.
[25] A. Stefani,et al. Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease. , 2012, Parkinsonism & related disorders.
[26] K. Bertram,et al. Visual hallucinations in the differential diagnosis of parkinsonism , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[27] W. Oertel,et al. Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy , 2011, Neurodegenerative Diseases.
[28] M. Hashimoto,et al. Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic , 2011, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[29] J. Hodges,et al. Behavioural symptoms in progressive supranuclear palsy and frontotemporal dementia , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[30] A. Lees,et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. , 2010, Brain : a journal of neurology.
[31] M. Jahanshahi,et al. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.
[32] A. Kertesz,et al. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy , 2010, Journal of the Neurological Sciences.
[33] Nir Giladi,et al. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood , 2010, Journal of Neural Transmission.
[34] C. Antke,et al. In vivo imaging of synaptic function in the central nervous system I. Movement disorders and dementia , 2009, Behavioural Brain Research.
[35] A. Calder,et al. Emotion recognition in progressive supranuclear palsy , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[36] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.
[37] B. Borroni,et al. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy , 2009, International Psychogeriatrics.
[38] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[39] B. Borroni,et al. Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. , 2008, Archives of gerontology and geriatrics (Print).
[40] K. Ito,et al. Cognitive impairments in multiple system atrophy , 2008, Neurology.
[41] G. Halliday,et al. Excessive dopamine neuron loss in progressive supranuclear palsy , 2008, Movement disorders : official journal of the Movement Disorder Society.
[42] J. Parisi,et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy , 2008, Neurology.
[43] H. Amthauer,et al. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration , 2006, Movement disorders : official journal of the Movement Disorder Society.
[44] M. T. Pellecchia,et al. Health‐related quality of life in multiple system atrophy , 2006, Movement disorders : official journal of the Movement Disorder Society.
[45] D. Mash,et al. Visual Hallucinations in Progressive Supranuclear Palsy , 2006, European Neurology.
[46] R. Moretti,et al. Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration , 2005, Dementia and Geriatric Cognitive Disorders.
[47] A. Schrag,et al. Depressive symptoms and life satisfaction in patients with multiple system atrophy , 2005, Movement disorders : official journal of the Movement Disorder Society.
[48] A. Lees,et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.
[49] M. Jahanshahi,et al. Health‐related quality of life in patients with progressive supranuclear palsy , 2003, Movement disorders : official journal of the Movement Disorder Society.
[50] E. Benarroch. Brainstem in Multiple System Atrophy: Clinicopathological Correlations , 2003, Cellular and Molecular Neurobiology.
[51] D. Dickson,et al. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.
[52] J. Parisi,et al. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy , 2002, Neurology.
[53] I Litvan,et al. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.
[54] Y Ben-Shlomo,et al. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study , 1999, The Lancet.
[55] S Tanada,et al. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy , 1999, Annals of neurology.
[56] F. Girotti,et al. Affective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapy , 1999, Journal of neurology, neurosurgery, and psychiatry.
[57] R. Khurana,et al. Occurrence of depressive symptoms in Shy-Drager syndrome , 1999, Clinical Autonomic Research.
[58] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[59] M. Mega,et al. Neuropsychiatric features of corticobasal degeneration , 1998, Journal of neurology, neurosurgery, and psychiatry.
[60] I Litvan,et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination , 1998, Journal of neurology, neurosurgery, and psychiatry.
[61] Jeffrey L. Cummings,et al. Neuropsychiatric aspects of progressive supranuclear palsy , 1996, Neurology.
[62] J. Hodges,et al. Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy , 1996, Journal of Neurology.
[63] M. Trimble,et al. Depression in multiple system atrophy and in idiopathic Parkinson's disease: A pilot comparative study , 1996, Biological Psychiatry.
[64] R. Doody,et al. Neuropsychological functioning in cortical-basal ganglionic degeneration , 1996, Neurology.
[65] L. Golbe,et al. Psychiatric symptoms in progressive supranuclear palsy. , 1995, Psychosomatics.
[66] P. Lantos,et al. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy , 1992, Journal of the Neurological Sciences.
[67] A. Lees,et al. The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1986, Neurology.
[68] E. Hirsch,et al. Dopaminergic and cholinergic lesions in progressive supranuclear palsy , 1985, Annals of neurology.
[69] J. Hodges,et al. Explorer Validation of the new consensus criteria for the diagnosis of corticobasal degeneration , 2016 .
[70] R. Petersen,et al. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. , 2007, The Journal of neuropsychiatry and clinical neurosciences.
[71] M. Albert,et al. Corticobasal degeneration: neuropsychological and clinical correlates. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[72] K. Shannak,et al. Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease. , 1994, Journal of neural transmission. Supplementum.